Callisto BioMed is a cardiovascular diagnostics company delivering next-generation HDL and LDL subfraction analysis to improve early risk detection.
Our microfluidics-based LipoSpec platform provides automated, high-resolution subfraction profiling with greater than 80% specificity today—far exceeding conventional lipid tests. We have a partner CLIA partner lab offering the service to clinicians, pharma companies and cardiovascular researchers. 
We empower preventive cardiology, concierge medicine, and research partners with deeper lipid insights that reveal risk patterns hidden in standard cholesterol panels.

Callisto BioMed

Org chart

Teams

Offices